- Antimicrobials ×
-
Bactobio X Microbiology Society
November 1, 2023
Bactobio is a biotechnology company that uses next-generation sequencing, machine learning and bioengineering to culture the 99% of microbes which have previously been unculturable. Their first targets are to discover novel antibiotics against the most pressing bacterial infections and help make plant protection sustainable.
We spoke to Microbiology Society member, Dr Mark Wilkinson, Co-founder and Chief Scientific Officer of Bactobio to find out more about how they are hoping to tackle the antimicrobial resistance crisis. -
Podcast: Inside the creeping threat of fungal infections
November 23, 2022
Some fungal infections, like athletes' foot or thrush, are relatively common and are usually not serious. But in those with underlying conditions or compromised immune systems, fungal infections can be deadly.
In recent weeks, the World Health Organisation has warned of the serious threat that fungi pose to humans with a new report and list of priority fungal pathogens. In this episode of Microbe Talk, Charlotte takes a look inside the creeping threat of fungal infections with guests Prof Kevin Kavanagh and Prof Neil Gow.
-
Combatting antimicrobial resistance in Benin
May 10, 2021
Antimicrobial resistance is a major public health problem worldwide. The World Health Organization (WHO) is making it a priority, intensifying both prevention strategies based on awareness, monitoring and eradication. In developing countries, scientific research is a strong weapon to optimise the diagnosis of antimicrobial resistance and propose alternatives. In this blog, Microbiology Society Champion Dr Victorien Tamègnon Dougnon discusses his research into developing drugs from medicinal plants.
-
Diving for antibiotics
August 24, 2020
In this blog post, Emily Addington describes her experience developing an outreach project called 'Dive for Antibiotics'. Emily carried out this project with a grant from the Microbiology Society and presented her project at the President's Roadshow in Strathclyde.
-
Microbiology Editor’s Choice: induction of protein expression by cell wall targeting antibiotics
August 3, 2020
Each month, a manuscript published in our flagship journal Microbiology is chosen by a member of the Editorial Board. This month, the paper is titled ‘Induction of clpP expression by cell wall targeting antibiotics in Streptococcus mutans’ and was chosen by Professor Isabelle Martin-Verstraete.
-
Microbe Talk: Improving the lifespan of antibiotics in Canada
August 9, 2019
This month on the podcast, we spoke with Dr Mayri Alessandra Diaz De Rienzo, Ale for short, who is lecturer in Biotechnology at Liverpool John Moores University, UK. Ale is currently in Quebec, Canada, visiting the lab of Professor Eric Déziel on a Microbiology Society Research Visit Grant. Ale has travelled to Canada to research how biosurfactants can work with antibiotics to make infections easier to treat, and how they might be able to improve the lifespan of antibiotics.
-
Can we evolve our own antimicrobials?
July 17, 2019
Our antimicrobials are slowly being rendered useless. Could it be that we have been producing outdated antimicrobials, while the organisms that naturally produce them have been continuously adapting and changing them? I am a master’s student at Imperial College London, and I have been researching this topic for the past nine months to try and find some answers.
-
New antibiotics needed: Haemophilus influenzae
March 14, 2019
In 2017, the World Health Organization (WHO) published the ’12 Priority Pathogens’: a list of twelve microbes that are becoming increasingly resistant to current antimicrobials. These twelve pathogens are thought by WHO to pose the greatest threat to human health.
